The four entities of anaplastic large cell lymphomas (ALCLs) are identical in both proposals: ALK-positive (ALK+) and ALK-negative (ALK−) ALCL, primary cutaneous ALCL (within the spectrum of CD30-positive cutaneous T cell lymphoproliferative disorders), and breast implant-associated (BIA-)ALCL. The gene discussed is TNFRSF8; the disease is anaplastic large cell lymphoma.